Abiopharma

🔍 MCGEE SUSAN B (Director)

Company: HIVE Digital Technologies Ltd. (HIVE)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Acquired 100,000 shares of Common Shares (Direct)
  Date: 2026-04-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 212,500.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 100,000 shares of Restricted stock units (Derivative)
  Date: 2026-04-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 337,500.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F3

Footnotes:

• F1: Reflects restricted stock units ("RSUs") that upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis.
• F2: Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer.
• F3: The RSUs reported under Column 9 include four additional RSU awards that were previously reported. The underlying shares and vesting schedules are as follows: (i) 37,5000 vest in three equal installments on May 5, 2026, August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.